(A) For purposes of division (B)(2)(b) of section 4730.46 of the Revised Code, a course of study is clinically relevant to the practice of physician assistants if it is a biological science related to the anatomy and physiology of the human body.
(1) The course of study may include, but is not necessarily limited to, the following: anatomy, biochemistry, physiology, microbiology, pharmacology, genetics, neuro-science and molecular biology, occupational therapy, physical therapy, exercise physiology, public health, physician assistant studies, athletic training, medical sciences, and psychology.
(2) Courses of study not acceptable include, but are not necessarily limited to, business, economics, ethics, history, and other fields not related to biological science.
(B) Pharmacology instruction required by division (A)(2) of section 4730.46 of the Revised Code shall be met by completion of a course of study consisting of planned classroom or continuing education and clinical study as follows:
(1) The course of study meets one of the following requirements:
(a) It is provided as part of a physician assistant education program accredited by the ARC-PA; or
(b) It is approved by the board pursuant to paragraphs (C), (D) and (E) of this rule.
(2) The content of the course of study includes all of the following:
(a) A minimum of thirty contact hours of training in pharmacology that includes pharmacokinetic principles and clinical application and the use of drugs and therapeutic devices in the prevention of illness and maintenance of health;
(b) A minimum of twenty contact hours of clinical training in pharmacology; and
(c) A minimum of fifteen contact hours including training in the fiscal and ethical implications of prescribing drugs and therapeutic devices and training in the state and federal laws that apply to the authority to prescribe.
(C) Coursework meeting the course content required in paragraph (B)(2)(a) of this rule shall be deemed approved by the board if it meets one of the following requirements:
(1) The coursework is approved for category I CME credit by AAPA or an institution or organization accredited to provide CME by the ACCME; or
(D) Clinical training in pharmacology providing twenty contact hours in clinical pharmacology shall be deemed approved by the board for purposes of paragraph (B)(2)(b) of this rule, if it meets one of the following requirements:
(1) The clinical training meets all of the following requirements:
(a) The clinical training is conducted under the on-site supervision and direction of a supervising physician;
(b) The clinical training includes a process for regular interaction between the supervising physician and the physician assistant for on-going discussion concerning the physician assistant's prescriptive decisions;
(c) The clinical training includes evaluation of the physician assistant's learning of the principles of the use of drugs and therapeutic devices in the prevention of illness and maintenance of health; and
(d) The clinical training requires the physician assistant to apply pharmacologic principles and precepts in prescribing for a variety of medical conditions.
(2) The clinical training of a physician assistant who has been granted physician delegated prescriptive authority in another jurisdiction shall be deemed approved by the board upon receipt of an affidavit, from the physician licensed in that state who supervised the physician assistant in the exercise of physician delegated prescriptive authority, stating that the physician assistant has met the clinical training requirements provided in this rule.
(E) Coursework meeting the course content required in paragraph (B)(2)(c) of this rule shall be deemed approved by the board if it is approved for category I CME credit by AAPA or an institution or organization accredited to provide CME by the ACCME.